FAVORABLE OUTCOME OF PREGNANCY IN WOMEN WITH ANTIPHOSPHOLIPID SYNDROME UNDER BEMIPARIN USAGE
Woman had only one pregnancy that ended with fetus death. Definite antiphospholipid syndrome and genetic thrombophilia of moderate risk were identified. Promptly undertaken diagnostic measures and pharmacological correction with low molecular weight heparin - Be- miparin in preventative dose 2500 IU per day allowed to achieve a favorable outcome of the first pregnancy after stillbirth. During treatment hemorrhagic manifestations were not registered.